AIC
CNCE

Ameritas Investment Company’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Ameritas Investment Company’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-97
Closed -$484 – 2210
2021
Q1 		$484 Buy
+97
New +$784 ﹤0.01% 2181
2020
Q2 		– Sell
-97
Closed -$1K – 1717
2020
Q1 		$1K Buy
+97
New +$956 ﹤0.01% 1725
2019
Q2 		– Sell
-97
Closed -$1K – 934
2019
Q1 		$1K Buy
+97
New +$1.43K ﹤0.01% 918

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameritas Investment Company's CNCE Position: Q2 2021 in Review

Ameritas Investment Company sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 97 shares — an estimated $484 sold.

Ameritas Investment Company first reported a position in CNCE in Q1 2019 and held it in 3 quarters. The position peaked at $1K in Q1 2020. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • Ameritas Investment Company reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 97 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $484.
  • Ameritas Investment Company first reported a position in Concert Pharmaceuticals, Inc. in Q1 2019 and held it in 3 quarters.
  • Ameritas Investment Company's Concert Pharmaceuticals, Inc. position peaked at $1K in Q1 2020.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.